Cillian Murphy will be playing American physicist J Robert Oppenheimer in Christopher Nolan’s upcoming historical epic, which is all set to hit the theatres in North America on July 21, 2023. The $100-million movie is Nolan’s first big studio project after parting ways with Warner Bros.

Murphy has previously starred in Nolan’s movies including “Batman Begins,” “Inception,” and “Dunkirk.”

Written by Nolan and produced by Emma Thomas and Charles Roven, the movie is adapted from the Pultizer Prize-winning book “American Prometheus: The Triumph and Tragedy of J. Robert Oppenheimer” by Kai Bird and Martin J. Sherwin.

Also Read: 5 Christopher Nolan’s films one must watch

For this film, Nolan will reunite with past collaborators including director of photography Hoyte Van Hoytema, editor Jennifer Lame and composer Ludwig Göransson.

“Christopher Nolan and Emma Thomas’ films have shattered the limits of what cinematic storytelling can achieve. We are thrilled to be working alongside them on this exceptional and extraordinary project and are grateful for their shared passion and commitment to the theatrical experience,” said Universal Filmed Entertainment Group Chairman Donna Langley in a statement. 

Also Read: How Christopher Nolan’s interest in Bruce Wayne gave birth to ‘Batman Begins’

Since the 2002 movie “Insomnia” and to 2020’s “Tenet,” Nolan made all of his movies for Warner Bros. The company, however, delayed the release of “Tenet” three times before eventually dropping the movie in whatever theaters were possible on September 3.

Expressing his disbelief over Warners’ handling of new releases, Nolan said in an interview, “There’s such controversy around it, because they didn’t tell anyone. In 2021, they’ve got some of the top filmmakers in the world, they’ve got some of the biggest stars in the world who worked for years in some cases on these projects very close to their hearts that are meant to be big-screen experiences. They’re meant to be out there for the widest possible audiences… And now they’re being used as a loss-leader for the streaming service — for the fledgling streaming service — without any consultation. So, there’s a lot of controversy.”